Skip to main content
Clinical Trials/ACTRN12609000462280
ACTRN12609000462280CompletedPhase 4

A two part study to compare the pharmacological effects of recombinant human chorionic gonadotrophin (rhCG/Ovidrel) versus urinary human chorionic gonadotrophin (uhCG/Pregnyl) given as subcutaneous injection to healthy men following supression of endogenous testosterone (T) and luteinising hormone (LH) with nandrolone decanoate(ND).

Concord Repatriation General Hospital (CRGH)0 sites32 target enrollmentStarted: June 16, 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
32

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
Male

Inclusion Criteria

  • Healthy men over 18 years of age

Exclusion Criteria

  • History of:
  • 1. Chronic disease or condition requiring regular medical treatment,
  • 2. Male infertility or pituitary-testicular dysfunction
  • 3. Androgen (anabolic steriod) use or abuse

Investigators

Sponsor
Concord Repatriation General Hospital (CRGH)

Similar Trials